Experienced in Major Depression

Aurelie Schandrin

CHU Nîmes, Univ Montpellier
Nimes, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Major Depression
CHU Nîmes, Univ Montpellier
Nimes, FR 
OverviewLocationsClinical Research

Overview

Aurelie Schandrin practices in Nimes, France. Ms. Schandrin is rated as an Experienced expert by MediFind in the treatment of Major Depression. Her top areas of expertise are Schizophrenia, Abdominal Obesity Metabolic Syndrome, Metabolic Syndrome, and Secondary Parkinsonism.

Her clinical research consists of co-authoring 37 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Major Depression.

Gender
Female

Locations

CHU Nîmes, Univ Montpellier
Nimes, France
Other Locations
Creteil, France
Bordeaux, 33000, France
Montpellier, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Evaluation of the Impact of Case Manager Intervention on the 3-year Psychotic Episode Recurrence Rate in Patients Aged 16 to 30 Years with a First Psychotic Episode. Randomized, Open-label, Multicenter Controlled Study with Blinded Evaluation.
Evaluation of the Impact of Case Manager Intervention on the 3-year Psychotic Episode Recurrence Rate in Patients Aged 16 to 30 Years with a First Psychotic Episode. Randomized, Open-label, Multicenter Controlled Study with Blinded Evaluation.
Enrollment Status: Recruiting
Publish Date: February 13, 2025
Intervention Type: Other
Study Phase: Not Applicable

37 Total Publications

PEPsy-CM study protocol: impact of a 3-year program for early psychosis based on case-management on relapse rate, a French multicenter randomized trial.
PEPsy-CM study protocol: impact of a 3-year program for early psychosis based on case-management on relapse rate, a French multicenter randomized trial.
Journal: BMC psychiatry
Published: June 09, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Schandrin's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile